Thursday, 7 November 2024
  
Login

Australia's most trusted
source of pharma news

Thursday, 07 November 2024
News

AZ plummets as China investigates

Posted 7 November 2024 AM

AstraZeneca lost $25.9 billion in market value on Monday in a fall attributed to an ongoing Chinese investigation into the company coupled with disappointing results for its obesity candidate.

The woes started in early September with reports Chinese police had detained five current and former AstraZeneca employees in relation to an investigation into possible breaches relating to data privacy and importing unlicensed medications, with that number now understood to be eight or nine.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (15)

Access & Reimbursement (1)

Clinical & Medical, R&D (10)

Regulatory, Pharmacovigilance & QA (3)

Other (13)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.